October 10, 2017 / 5:44 AM / 2 years ago

BRIEF-Nicox and pSivida enter collaboration agreement to develop sustained release drug for glaucoma patients​

Oct 10 (Reuters) - Nicox SA

* Nicox-Co and pSivida enter strategic collaboration agreement to develop sustained release drug to lower intraocular pressure in patients with glaucoma​

* Would make additional payments for any incremental development activities for each implant formulation product candidate

* Expected payments from Nicox associated with agreement are not considered material to Nicox’s financial statements at this time​

* Says ‍pSivida will be responsible for initial development activities of ocular insert formulations, for which it will receive undisclosed sums​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below